Our virtual trip to the USA

15. July 2021 In Blog

Our virtual trip to the USA

Dynamic42 in the USA

We want to take the plunge across the pond! From 06/28 to 07/01/2021 we participated in the intensive workshop Step USA Virtual. It is a very successful and highly informative program that focuses on facilitating market access in the USA for young innovative companies from Germany. The concept was launched by the German American Chamber of Commerce New York (GACC NY) and took place in cooperation with the Frankfurt Main Chamber of Industry and Commerce, the Hessian Ministry of Economic Affairs, Energy, Transport and Housing, the Start Hub Hessen, the TechQuartier, the Stiftung für Technologie, Innovation und Forschung Thüringen (STIFT) and bm-t beteiligungsmanagement thüringen gmbh.

Our managing directors Dr. Martin Raasch and Dr. Knut Rennert received an excellent overview of the US market and learned where the special challenges lie and where they can receive support. “We gained insights into American customs and cultural differences and were able to practice how to pitch your corporate philosophy/vision in front of an American investor. In addition, we learned which legal requirements must be fulfilled for a company to be founded in the USA. One fact became clear: trust is more likely to be placed in a US subsidiary than in an unknown German start-up.

We were accompanied by Andrea Diewald and Irene Fuchs from GACC NY as well as a very good mix of speakers from a wide variety of specialist areas. We would like to thank the organizers of the Step USA Workshop for the successful event, which was very profitable for us.

Will organ-on-chip replace animal testing?

Will advanced in vitro models such as organ-on-chip replace animal testing? An opinion piece by our CEO and co-foudner Dr. Martin Raasch.

When butyrate drops, the gut loses more than a metabolite – it loses resilience

In this new study by Manuel Allwang, Maximilian Wipplinger, and Parastoo Akbarimoghaddam and colleagues, published in Small, the authors show why that loss may be especially important when inflamed tissue is challenged by the opportunistic fungus Candida albicans.